Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency-Reference-Cited by-同舟云学术

Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency

Published:2021 Issue:7 Volume:121 Page:84
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Kurkin D.V.,Morkovin E.I.,Kalatanova A.V.,Bakulin D.A.,Verholyak D.V.,Kovalev N.S.,Dubrovina M.A.,Tyurenkov I.N.,Petrov V.I.

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference17 articles.

1. Abdrachmanova MG, Omarova SK, Alyeva AM. Effectiveness of Cortexin with cognitive impairment in patients with ischemic stroke. Vestnik KazNMU. 2015;(2):326-330. (In Russ.)

2. Plavinski SL, Shabalkin PI. A meta-analysis. Cerebrolisyn, Cortexin, Cellex, efficiency in vascular dementia, Alzheimer’s disease and ischemic stroke. Medicina. 2016;4(2):1-15. (In Russ.)

3. An analysis of the peptide composition of a 'light' peptide fraction of cerebrolysin

4. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin)

5. Shabanov PD. Pharmacology of drugs of peptide structure. Psihofarmakologija i biologicheskaja narkologija. 2008;8(3-4):2399-2425. (In Russ.)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of peptide bioregulators on the resistance of the organism to adverse effects;Reviews on Clinical Pharmacology and Drug Therapy;2023-08-01

2. Treatment of diseases with consequences of traumatic brain injury;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023